The following products have been found matching your search "though": 239
Or did you mean: FIND ME THIS PAPER Ball et al. (2022): This study highlights the increased incidence of hypoglycemic episodes in diabetic patients, particularly those with Type 1 diabetes, due to disruptions in glucose homeostasis during fasting periods. The study unders | throughput | thus | through | thousand | thought | although | those
No results were found for the filter!
FITC
CyFlow™ IgE FITC
Antigen: | IgE |
Clone: | BE5 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
$235.00 USD
PE
CyFlow™ IgE PE
Antigen: | IgE |
Clone: | BE5 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
$255.00 USD
PE-Cy5
CyFlow™ IgE PE-Cy5
Antigen: | IgE |
Clone: | BE5 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
$285.00 USD
Purified
CyFlow™ IgE Purified
Antigen: | IgE |
Clone: | BE5 |
Application: | Enzyme-linked immunosorbent assay, Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
$120.00 USD
PE
CyFlow™ OPAL1 PE
Antigen: | OPAL1 |
Clone: | OPAL1-01 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
$255.00 USD
Purified
CyFlow™ OPAL1 Purified
Antigen: | OPAL1 |
Clone: | OPAL1-01 |
Application: | Flow cytometry, Western blot |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
$120.00 USD